Lipocine to present at h.c. wainwright 8th annual mash investor conference

Salt lake city , sept. 30, 2024 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that it will present and meet with investors at the h.c.
LPCN Ratings Summary
LPCN Quant Ranking